Damià Romero–Moya

612 total citations
20 papers, 300 citations indexed

About

Damià Romero–Moya is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Damià Romero–Moya has authored 20 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Hematology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Damià Romero–Moya's work include Acute Myeloid Leukemia Research (10 papers), CRISPR and Genetic Engineering (7 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Damià Romero–Moya is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), CRISPR and Genetic Engineering (7 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Damià Romero–Moya collaborates with scholars based in Spain, United States and Germany. Damià Romero–Moya's co-authors include Pablo Menéndez, Clara Bueno, Rosa Montes, Óscar Navarro-Montero, Julio Castaño, Alessandra Giorgetti, Verónica Ramos–Mejía, Francisco J. Iborra, Miguel Martı́n and Luís C. López and has published in prestigious journals such as Blood, Oncogene and Stem Cells.

In The Last Decade

Damià Romero–Moya

19 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Damià Romero–Moya Spain 11 192 130 58 54 42 20 300
Danika Di Giacomo Italy 9 189 1.0× 82 0.6× 25 0.4× 26 0.5× 48 1.1× 17 292
Thien N. Sam United States 6 202 1.1× 161 1.2× 20 0.3× 40 0.7× 39 0.9× 7 310
Tanya A. Kranenburg United States 5 155 0.8× 88 0.7× 37 0.6× 27 0.5× 13 0.3× 5 225
Giulia Pianigiani Italy 10 283 1.5× 97 0.7× 46 0.8× 15 0.3× 12 0.3× 17 347
Guy Ledergor United States 6 141 0.7× 140 1.1× 54 0.9× 68 1.3× 8 0.2× 10 303
Reina Takeda Japan 7 152 0.8× 177 1.4× 77 1.3× 18 0.3× 20 0.5× 12 275
Jana Lentes Germany 8 150 0.8× 69 0.5× 18 0.3× 19 0.4× 76 1.8× 15 266
R. Tanner Hagelstrom United States 9 229 1.2× 49 0.4× 19 0.3× 47 0.9× 26 0.6× 16 325
Manuela Kampfmann Germany 6 319 1.7× 201 1.5× 49 0.8× 95 1.8× 18 0.4× 7 465
Katharina Boroviak United Kingdom 8 270 1.4× 57 0.4× 36 0.6× 38 0.7× 15 0.4× 8 361

Countries citing papers authored by Damià Romero–Moya

Since Specialization
Citations

This map shows the geographic impact of Damià Romero–Moya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damià Romero–Moya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damià Romero–Moya more than expected).

Fields of papers citing papers by Damià Romero–Moya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damià Romero–Moya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damià Romero–Moya. The network helps show where Damià Romero–Moya may publish in the future.

Co-authorship network of co-authors of Damià Romero–Moya

This figure shows the co-authorship network connecting the top 25 collaborators of Damià Romero–Moya. A scholar is included among the top collaborators of Damià Romero–Moya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damià Romero–Moya. Damià Romero–Moya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romero–Moya, Damià, Cristina Calvo, Oskar Marín-Béjar, et al.. (2025). CRISPR-engineered human GATA2 deficiency model uncovers mitotic dysfunction and premature aging in HSPCs, impairing hematopoietic fitness. Leukemia. 39(12). 3015–3025.
2.
Romero–Moya, Damià, Oskar Marín-Béjar, Laura Murillo, et al.. (2025). Multiple phenotypes and epigenetic profiles in a three-generation family history with GATA2 deficiency. Leukemia. 39(4). 962–966. 1 indexed citations
3.
Romero–Moya, Damià, Oskar Marín-Béjar, Emilia J. Kozyra, et al.. (2022). GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects. British Journal of Haematology. 199(4). 482–495. 18 indexed citations
4.
Pera, Joan, et al.. (2022). Generation of heterozygous SAMD9 CRISPR/Cas9-edited iPSC line (ESi086-A-3), carrying p.I1567M mutation. Stem Cell Research. 64. 102906–102906. 3 indexed citations
5.
Romero–Moya, Damià, Oskar Marín-Béjar, Joan Pera, et al.. (2022). Multiplex CRISPR/Cas9 Gene Editing in Human Stem Cells to Model Clonal Competition in GATA2 Deficiency. Blood. 140(Supplement 1). 8664–8665. 1 indexed citations
6.
Castaño, Julio, Damià Romero–Moya, Yvonne Richaud‐Patín, & Alessandra Giorgetti. (2021). Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency. Stem Cell Research. 55. 102445–102445. 6 indexed citations
7.
Karra, Laila, Damià Romero–Moya, Zhaohui Gu, et al.. (2020). Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis. Oncogene. 39(45). 6920–6934. 3 indexed citations
8.
Myers, Darienne R., et al.. (2020). Protocol for Barcoding T Cells Combined with Timed Stimulations. STAR Protocols. 1(2). 100067–100067. 2 indexed citations
9.
Mues, Marsilius, Laila Karra, Damià Romero–Moya, et al.. (2019). High-Complexity shRNA Libraries and PI3 Kinase Inhibition in Cancer: High-Fidelity Synthetic Lethality Predictions. Cell Reports. 27(2). 631–647.e5. 5 indexed citations
10.
López‐Millán, Belén, Rafael Díaz de la Guardia, Heleia Roca-Ho, et al.. (2018). IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML. OncoImmunology. 7(9). e1477460–e1477460. 11 indexed citations
11.
Navarro-Montero, Óscar, Verónica Ayllón, Lourdes López-Onieva, et al.. (2017). RUNX1cRegulates Hematopoietic Differentiation of Human Pluripotent Stem Cells Possibly in Cooperation with Proinflammatory Signaling. Stem Cells. 35(11). 2253–2266. 17 indexed citations
12.
Roon, Eddy H.J. Van, Damià Romero–Moya, Belén López‐Millán, et al.. (2016). Cellular Ontogeny and Hierarchy Influence the Reprogramming Efficiency of Human B Cells into Induced Pluripotent Stem Cells. Stem Cells. 34(3). 581–587. 12 indexed citations
13.
Romero–Moya, Damià, Julio Castaño, Carlos Santos‐Ocaña, Plácido Navas, & Pablo Menéndez. (2016). Generation, genome edition and characterization of iPSC lines from a patient with coenzyme Q 10 deficiency harboring a heterozygous mutation in COQ4 gene. Stem Cell Research. 24. 144–147. 14 indexed citations
14.
Sanjuán-Pla, Alejandra, Damià Romero–Moya, Cristina Prieto, et al.. (2015). Intra-Bone Marrow Transplantation Confers Superior Multilineage Engraftment of Murine Aorta-Gonad Mesonephros Cells Over Intravenous Transplantation. Stem Cells and Development. 25(3). 259–265. 7 indexed citations
15.
Bueno, Clara, José Luis Sardina, Bruno Di Stefano, et al.. (2015). Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα. Leukemia. 30(3). 674–682. 33 indexed citations
16.
Velasco, Iván, Patricia Salazar, Alessandra Giorgetti, et al.. (2014). Concise Review: Generation of Neurons From Somatic Cells of Healthy Individuals and Neurological Patients Through Induced Pluripotency or Direct Conversion. Stem Cells. 32(11). 2811–2817. 36 indexed citations
17.
Bueno, Clara, Eduardo Anguita, Damià Romero–Moya, et al.. (2014). Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease. Haematologica. 99(7). 1168–1175. 24 indexed citations
18.
Romero–Moya, Damià, Clara Bueno, Rosa Montes, et al.. (2013). Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function. Haematologica. 98(7). 1022–1029. 61 indexed citations
19.
Montes, Rosa, Verónica Ayllón, Cristina Prieto, et al.. (2013). Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells. Leukemia. 28(3). 666–674. 18 indexed citations
20.
Bueno, Clara, Verónica Ayllón, Rosa Montes, et al.. (2013). FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs. Blood. 121(19). 3867–3878. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026